May 10, 2021: – Shares of two Covid vaccine makers seesawed after the Biden administration announced it would back a motion before the World Trade Organization to waive mRNA technology patent protections used in vaccine making.
On Thursday, Pfizer came down by 5% from Wednesday’s close, while Moderna dipped by nearly 12% before both stocks recovered the losses. The companies use the same mRNA technology to make their doses.
South Africa and India are pressing U.S. officials and the WTO to temporarily waive patent protections so developing countries can produce lifesaving vaccines until world leaders can get the pandemic under control.
Human rights organizations such as Doctors Without Borders, Oxfam, and Amnesty International have signed on to the letter supporting the proposal. U.S. Trade Representative Katherine Tai said on Wednesday evening backing the waiver.
“This is a global health crisis, and the extraordinary circumstances of the COVID-19 pandemic call for extraordinary measures,” she said. “The Administration believes strongly in intellectual property protections, but in service of ending this pandemic, supports the waiver of those protections for COVID-19 vaccines.”
President Joe Biden made a campaign promise last year to “absolutely, positively” waive vaccine patents. Waiving the patent protections could take months or even years.
“We believe any new manufacturing operation could take 6 to 9 months to scale, effectively limiting the impact of other producers. Thus, while we expect pressure on mRNA from the headlines, we do not see significant practical implications from this news,” analysts at Morgan Stanley said in a research note on Thursday.
They also note that “U.S. support is not the same as approval where WTO decisions require consensus, and other members such as the E.U., U.K., Japan, and Switzerland currently oppose waiving I.P.”
Both Pfizer and Moderna already have plans in motion to produce billions of doses in the meantime, essentially leaving any competitors far behind in the manufacturing process.
We provide the insights on leaders who are responsible for taking their organization to new heights, all the while bringing together a group of talented individuals.
January 23, 2025: A historic snowstorm has paralyzed parts of the southern United States, including Louisiana and Texas. It brought unprecedented snowfall
The healthcare industry is undergoing a seismic shift fueled by artificial intelligence (AI) and telemedicine.
January 22, 2025: President Donald Trump has announced a $500 billion AI infrastructure initiative, named “Stargate,”
January 20, 2025: The United States has intensified its trade restrictions on Chinese technology companies, specifically targeting entities specializing in AI.
January 16, 2025: Canada is bracing for a potential trade conflict with the United States as President-elect Donald Trump threatens to impose a 25% tariff
January 15, 2025: SpaceX has successfully launched two lunar missions aboard a single Falcon 9 rocket